Cardinal Health Inc. ($CAH) Stock Forecast: Down 3.7% Today

What is Cardinal Health Inc.?

Cardinal Health (CAH) is a multinational healthcare services company focusing on pharmaceutical and medical product distribution globally, catering to pharmacies, hospitals, and clinics. The healthcare stock market sentiment has been varied lately, with certain companies showing better performance than others.

Why is Cardinal Health Inc. going down?

CAH stock is down 3.7% on Oct 3, 2025 16:55

• Cardinal Health (CAH) may have faced a downward trend due to its underperformance relative to other medical stocks like Arcutis Biotherapeutics (ARQT).
• The subdued performance of CAH in the healthcare industry this year might be linked to the market's negative movement.
• Investors could be turning their attention towards more promising opportunities in the medical field, resulting in a sell-off of CAH shares.
• Contrasting with ARQT's strong showing could have revealed weaknesses in CAH's finances or growth prospects, prompting investors to review their positions and contributing to the bearish trend.

CAH Price Chart

CAH Technical Analysis

CAH News

Are Medical Stocks Lagging Arcutis Biotherapeutics ( ARQT ) This Year?

Here is how Arcutis Biotherapeutics, Inc. (ARQT) and Cardinal Health (CAH) have performed compared to their sector so far this year.

https://www.zacks.com/stock/news/2758931/are-medical-stocks-lagging-arcutis-biotherapeutics-arqt-this-year

Trending Today

Cardinal Health Inc. Price History

01.10.2024 - CAH Stock was up 6.4%

• In the first quarter of 2025, Cardinal Health (CAH) posted strong results, surpassing adjusted EPS expectations and outperforming sales consensus. The success was mainly attributed to the robust performance of its drug distribution business.
• By revising its profit outlook for 2025 upwards, the company demonstrates confidence in its growth path and ability to seize opportunities within the healthcare industry.
• Following the impressive earnings announcement, the market reacted positively to Cardinal Health, resulting in a bullish trend in the stock price. Investors appreciated the company's solid financial performance and strategic efforts to navigate supply chain obstacles.

01.10.2024 - CAH Stock was up 6.3%

• Cardinal Health (CAH) experienced a strong bullish movement today following its Q1 earnings report:
• The company beat expectations with first-quarter fiscal 2025 results, driven by solid growth in Pharmaceutical and Specialty Solutions.
• Despite a decrease in sales due to the OptumRx contract expiry, the raised earnings per share (EPS) outlook for 2025 boosted investor confidence.
• The positive market reaction can be attributed to:
• Strong performance in the drug distribution business, leading to an increase in adjusted operating earnings.
• Continued growth prospects supported by new facilities, acquisitions, and overcoming supply chain challenges.
• The market's focus on CAH's robust financial performance overshadowed concerns about sector comparisons and potential competition from other medical stocks like Atossa Genetics (ATOS).
• Overall, Cardinal Health's resilience and strategic initiatives in the healthcare sector have positioned the company favorably, driving investor optimism and contributing to today's bullish market movement.

31.00.2025 - CAH Stock was down 5.4%

• CAH reported strong Q2 earnings and sales that exceeded expectations, with an increase in the 2025 EPS view. Still, the negative impact of the OptumRx contract expiry on Pharmaceutical segment sales likely contributed to the bearish movement.
• The news of a Congress member buying up to $15K in Cardinal Health stock may have added some uncertainty or negative sentiment to the market, influencing the stock's downward trend.
• Despite solid revenue growth in the Other segment and increased sales in branded and specialty pharmaceuticals, concerns about the OptumRx contract expiry and supply-chain challenges may have overshadowed positive developments.
• Investors may approach Cardinal Health cautiously due to recent events and uncertainties surrounding the company's key segments and contracts.

06.00.2025 - CAH Stock was down 1.3%

• Despite CAH's strong quarterly results and robust product portfolio, the stock experienced a -1.02% decline in the most recent trading session.
• The market movement could be attributed to profit-taking by investors after a period of growth, leading to a temporary dip in the stock price.
• Investors might be reacting to broader market trends or sector-specific news impacting healthcare companies, causing a negative sentiment towards CAH in today's trading.

30.00.2025 - CAH Stock was up 0.0%

• The positive anticipation surrounding its upcoming Q2 earnings report, with growth in branded and specialty pharmaceutical sales expected to drive performance, could be a factor in the recent bullish movement in CAH.
• Market sentiment might have been influenced by a Congress member's purchase of Cardinal Health stock, signaling confidence in the company's future prospects.
• Contributing to the upward momentum in CAH's stock price could be the overall bullish trend in the market and the company hitting a 52-week high.

04.03.2025 - CAH Stock was down 5.6%

• CAH stock fell by 1.14% in the latest trading session.
• This downward movement could be related to market volatility or negative factors affecting the healthcare industry.
• Investors may be responding to worries about regulatory adjustments or changes in consumer healthcare demands.
• Traders should stay updated on company-specific updates and broader market patterns when considering CAH's stock.

11.11.2024 - CAH Stock was down 1.4%

• The strength in CAH's pharmaceutical segment and diversified product portfolio was not enough to counterbalance the challenges of concentrated revenue generation and regulatory setbacks.
• Concerns about concentrated revenue generation and regulatory setbacks seemed to heavily influence investor sentiment, causing a decline in CAH's stock.
• Despite the positive aspects of the company's business segments, challenges mentioned earlier seemed to overshadow potential gains, resulting in today's bearish market movement for CAH.

03.09.2025 - CAH Stock was down 3.7%

• Cardinal Health (CAH) may have faced a downward trend due to its underperformance relative to other medical stocks like Arcutis Biotherapeutics (ARQT).
• The subdued performance of CAH in the healthcare industry this year might be linked to the market's negative movement.
• Investors could be turning their attention towards more promising opportunities in the medical field, resulting in a sell-off of CAH shares.
• Contrasting with ARQT's strong showing could have revealed weaknesses in CAH's finances or growth prospects, prompting investors to review their positions and contributing to the bearish trend.

12.07.2025 - CAH Stock was down 7.3%

• There has been bullish options activity indicating positive sentiment from investors, although this did not result in a positive stock movement.
• The company exceeded earnings estimates and raised EPS guidance for 2026, leading to a stock drop potentially linked to concerns about the expiration of the OptumRx contract and its impact on Pharmaceutical segment sales.
• The upcoming release of Q4 earnings may have caused stock price volatility as investors reacted to forecast changes and dividend income strategies.
• A comparison with Adaptive Biotechnologies in the medical sector suggests that market dynamics and company-specific factors could have influenced Cardinal Health's bearish performance despite positive developments.

12.07.2025 - CAH Stock was down 12.2%

• The bearish movement in CAH stock could be attributed to investors' concerns about the upcoming earnings report falling short of expectations.
• Discussion about earning $500 a month from CAH stock might have raised unrealistic expectations among investors, leading to disappointment when the stock did not perform as anticipated.
• A comparison with Adaptive Biotechnologies (ADPT) might have highlighted stronger performance in the medical sector by ADPT, causing some investors to shift their focus away from CAH.
• Overall, the bearish movement in CAH could be a result of a combination of profit-taking, cautious investor sentiment ahead of the earnings report, and comparative underperformance within the sector.

14.07.2024 - CAH Stock was up 5.1%

• Cardinal Health Inc.'s stock experienced a strong bullish movement today.
• The surprising 11% stock rally can be attributed to the company exceeding fourth-quarter earnings and revenue estimates, driven by strong sales of pharmaceuticals.
• The positive earnings report, where Cardinal Health beat EPS and revenue expectations, along with raising its EPS guidance for fiscal 2024, likely fueled investor optimism and contributed to the bullish market movement.
• The market's positive reaction indicates investor confidence in Cardinal Health's financial performance and outlook, positioning the company favorably in the healthcare services sector.

10.05.2025 - CAH Stock was down 0.5%

• The overall market sentiment is bearish today.
• The bearish movement in CAH stock could be attributed to the announcement of a distribution services agreement between Citius Pharmaceuticals and Cardinal Health. This partnership might have raised concerns among investors about potential competition or changes in Cardinal Health's business strategy, leading to a negative impact on CAH stock price.